Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qihuang Yishen Granules for diabetic kidney disease
ChiCTR2200061809Phase 3
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Qihuang Yishen Granules in diabetic glomerulosclerosis (2 arms). Primary endpoint: 24-hour urine protein quantification.
02
Drugs
Qihuang Yishen Granules
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR2200061809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061809.